Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

CSL New Zealand Tetanus Immunoglobulin-VF (Human Tetanus Immunoglobulin), 250IU, solution for injection, vial (125817)

ARTG ID

125817

ARTG Name

CSL New Zealand Tetanus Immunoglobulin-VF (Human Tetanus Immunoglobulin), 250IU, solution for injection, vial

Sponsor

CSL Behring (Australia) Pty Ltd

ARTG Date

March 1, 2006

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Listed - Exempt

Sponsor Information

Sponsor Name

CSL Behring (Australia) Pty Ltd

Sponsor Item Name

CSL BEHRING (AUSTRALIA) PTY LTD

Active Ingredients

Ingredient Name

tetanus immunoglobulin

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy